Compare $APVO vs $HCWB | Chartloom

Compare

$APVO vs $HCWB

Aptevo Therapeutics Inc · HCW Biologics Inc

APVO

Aptevo Therapeutics Inc

HCWB

HCW Biologics Inc

Compare $APVO vs $HCWB

Comparing Aptevo Therapeutics Inc and HCW Biologics Inc

APVOAptevo Therapeutics Inc

HCWBHCW Biologics Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

HCWBHCW Biologics Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

707.0%

YTD performance

-76.2%

52W performance

-94.5%

FCF yield

-474.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

HCWB

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

HCWB

HCW Biologics Inc

Market Cap

APVO$2M

HCWB$3M

Enterprise Value

APVO$-8M

HCWB$8M

Price

APVO$1.79

HCWB$1.60

P/E Ratio

APVON/A

HCWBN/A

P/S Ratio

APVO0.25x

HCWB0.38x

EV/Sales

APVO-0.51x

HCWB1.25x

EV/EBITDA

APVO-0.91x

HCWB0.00x

P/B Ratio

APVO0.53x

HCWB0.51x

P/FCF Ratio

APVON/A

HCWBN/A

EV/FCF

APVO0.30x

HCWB-0.69x

PEG Ratio

APVON/A

HCWBN/A

Forward P/E (NTM)

APVON/A

HCWBN/A

Forward P/S (NTM)

APVON/A

HCWBN/A

Revenue (TTM)

APVO$0

HCWB$7M

Revenue Growth (YoY)

APVON/A

HCWB707.0%

Forward Rev Growth

APVO206.8%

HCWB5564.5%

Gross Margin (TTM)

APVO51.4%

HCWB95.9%

Operating Margin (TTM)

APVO0.0%

HCWB23.1%

EBITDA Margin (TTM)

APVO0.0%

HCWB-82.2%

Net Margin (TTM)

APVO0.0%

HCWB-318.5%

FCF Margin (TTM)

APVON/A

HCWB-180.6%

Net Income (TTM)

APVO$-28M

HCWB$-21M

FCF (TTM)

APVO$-25M

HCWB$-12M

EPS (TTM)

APVO-$23.47

HCWB-$16.12

ROE (TTM)

APVO-20149.0%

HCWB-1932.0%

ROA (TTM)

APVO-11921.0%

HCWB-2145.0%

ROIC (TTM)

APVO-20149.0%

HCWB-859.0%

Cash

APVO$10M

HCWB$741K

Debt

APVO$0

HCWB$7M

Net Cash/Debt

APVO$10M

HCWB$-6M

Current Ratio (TTM)

APVO2.08x

HCWB0.06x

Quick Ratio (TTM)

APVO1.98x

HCWB0.05x

Debt/Equity (TTM)

APVO0.00x

HCWB0.88x

Debt/Assets (TTM)

APVO0.0%

HCWB0.0%

Interest Coverage (TTM)

APVON/A

HCWBN/A

Net Debt/EBITDA (TTM)

APVO0.00x

HCWB0.00x

Beta

APVO1.68

HCWB2.28

52W Performance

APVO-94.2%

HCWB-94.5%

YTD Performance

APVO-80.9%

HCWB-76.2%

% from 52W High

APVO-94.6%

HCWB-94.3%

% from 52W Low

APVO30.7%

HCWB6.7%

Asset Turnover (TTM)

APVO0.22x

HCWB0.26x

FCF Yield (TTM)

APVO-1132.6%

HCWB-474.1%

Earnings Yield (TTM)

APVO-1254.8%

HCWB-836.3%

Dividend Yield (TTM)

APVON/A

HCWBN/A

Rule of 40

APVO0.0

HCWB526.4

EV/GP/RG

APVON/A

HCWB0.00

Ticker research

View APVO research View HCWB research

Metric	APVO Aptevo Therapeutics Inc	HCWB HCW Biologics Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$8M
Price	$1.79	$1.60
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.38x
EV/Sales	-0.51x	1.25x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	-0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	707.0%
Forward Rev Growth	206.8%	5564.5%
Profitability
Gross Margin (TTM)	51.4%	95.9%
Operating Margin (TTM)	0.0%	23.1%
EBITDA Margin (TTM)	0.0%	-82.2%
Net Margin (TTM)	0.0%	-318.5%
FCF Margin (TTM)	N/A	-180.6%
Net Income (TTM)	$-28M	$-21M
FCF (TTM)	$-25M	$-12M
EPS (TTM)	-$23.47	-$16.12
ROE (TTM)	-20149.0%	-1932.0%
ROA (TTM)	-11921.0%	-2145.0%
ROIC (TTM)	-20149.0%	-859.0%
Financial Health
Cash	$10M	$741K
Debt	$0	$7M
Net Cash/Debt	$10M	$-6M
Current Ratio (TTM)	2.08x	0.06x
Quick Ratio (TTM)	1.98x	0.05x
Debt/Equity (TTM)	0.00x	0.88x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.28
52W Performance	-94.2%	-94.5%
YTD Performance	-80.9%	-76.2%
% from 52W High	-94.6%	-94.3%
% from 52W Low	30.7%	6.7%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.26x
FCF Yield (TTM)	-1132.6%	-474.1%
Earnings Yield (TTM)	-1254.8%	-836.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	526.4
EV/GP/RG	N/A	0.00
Ticker research	View APVO research	View HCWB research

Valuation

P/S Ratio

APVO

0.25x

HCWB

0.38x

EV/FCF

HCWB

-0.69x

APVO

0.30x

Growth & revenue

Revenue Growth TTM

HCWB

707.0%

Forward Revenue Growth

HCWB

5564.5%

APVO

206.8%

Profitability & performance

Gross Margin

HCWB

95.9%

APVO

51.4%

ROE

HCWB

-1932.0%

APVO

-20149.0%

FCF Yield %

HCWB

-474.1%

APVO

-1132.6%

52-Week Performance

APVO

-94.2%

HCWB

-94.5%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

HCWB

HCW Biologics Inc

Market Cap

APVO$2M

HCWB$3M

Enterprise Value

APVO$-8M

HCWB$8M

Price

APVO$1.79

HCWB$1.60

P/E Ratio

APVON/A

HCWBN/A

P/S Ratio

APVO0.25x

HCWB0.38x

EV/Sales

APVO-0.51x

HCWB1.25x

EV/EBITDA

APVO-0.91x

HCWB0.00x

P/B Ratio

APVO0.53x

HCWB0.51x

P/FCF Ratio

APVON/A

HCWBN/A

EV/FCF

APVO0.30x

HCWB-0.69x

PEG Ratio

APVON/A

HCWBN/A

Forward P/E (NTM)

APVON/A

HCWBN/A

Forward P/S (NTM)

APVON/A

HCWBN/A

Revenue (TTM)

APVO$0

HCWB$7M

Revenue Growth (YoY)

APVON/A

HCWB707.0%

Forward Rev Growth

APVO206.8%

HCWB5564.5%

Gross Margin (TTM)

APVO51.4%

HCWB95.9%

Operating Margin (TTM)

APVO0.0%

HCWB23.1%

EBITDA Margin (TTM)

APVO0.0%

HCWB-82.2%

Net Margin (TTM)

APVO0.0%

HCWB-318.5%

FCF Margin (TTM)

APVON/A

HCWB-180.6%

Net Income (TTM)

APVO$-28M

HCWB$-21M

FCF (TTM)

APVO$-25M

HCWB$-12M

EPS (TTM)

APVO-$23.47

HCWB-$16.12

ROE (TTM)

APVO-20149.0%

HCWB-1932.0%

ROA (TTM)

APVO-11921.0%

HCWB-2145.0%

ROIC (TTM)

APVO-20149.0%

HCWB-859.0%

Cash

APVO$10M

HCWB$741K

Debt

APVO$0

HCWB$7M

Net Cash/Debt

APVO$10M

HCWB$-6M

Current Ratio (TTM)

APVO2.08x

HCWB0.06x

Quick Ratio (TTM)

APVO1.98x

HCWB0.05x

Debt/Equity (TTM)

APVO0.00x

HCWB0.88x

Debt/Assets (TTM)

APVO0.0%

HCWB0.0%

Interest Coverage (TTM)

APVON/A

HCWBN/A

Net Debt/EBITDA (TTM)

APVO0.00x

HCWB0.00x

Beta

APVO1.68

HCWB2.28

52W Performance

APVO-94.2%

HCWB-94.5%

YTD Performance

APVO-80.9%

HCWB-76.2%

% from 52W High

APVO-94.6%

HCWB-94.3%

% from 52W Low

APVO30.7%

HCWB6.7%

Asset Turnover (TTM)

APVO0.22x

HCWB0.26x

FCF Yield (TTM)

APVO-1132.6%

HCWB-474.1%

Earnings Yield (TTM)

APVO-1254.8%

HCWB-836.3%

Dividend Yield (TTM)

APVON/A

HCWBN/A

Rule of 40

APVO0.0

HCWB526.4

EV/GP/RG

APVON/A

HCWB0.00

Ticker research

View APVO research View HCWB research

Metric	APVO Aptevo Therapeutics Inc	HCWB HCW Biologics Inc
Market & Valuation
Market Cap	$2M	$3M
Enterprise Value	$-8M	$8M
Price	$1.79	$1.60
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	0.38x
EV/Sales	-0.51x	1.25x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.51x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	-0.69x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$7M
Revenue Growth (YoY)	N/A	707.0%
Forward Rev Growth	206.8%	5564.5%
Profitability
Gross Margin (TTM)	51.4%	95.9%
Operating Margin (TTM)	0.0%	23.1%
EBITDA Margin (TTM)	0.0%	-82.2%
Net Margin (TTM)	0.0%	-318.5%
FCF Margin (TTM)	N/A	-180.6%
Net Income (TTM)	$-28M	$-21M
FCF (TTM)	$-25M	$-12M
EPS (TTM)	-$23.47	-$16.12
ROE (TTM)	-20149.0%	-1932.0%
ROA (TTM)	-11921.0%	-2145.0%
ROIC (TTM)	-20149.0%	-859.0%
Financial Health
Cash	$10M	$741K
Debt	$0	$7M
Net Cash/Debt	$10M	$-6M
Current Ratio (TTM)	2.08x	0.06x
Quick Ratio (TTM)	1.98x	0.05x
Debt/Equity (TTM)	0.00x	0.88x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.28
52W Performance	-94.2%	-94.5%
YTD Performance	-80.9%	-76.2%
% from 52W High	-94.6%	-94.3%
% from 52W Low	30.7%	6.7%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.26x
FCF Yield (TTM)	-1132.6%	-474.1%
Earnings Yield (TTM)	-1254.8%	-836.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	526.4
EV/GP/RG	N/A	0.00
Ticker research	View APVO research	View HCWB research